IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract for the installation of a Proteus ONE proton therapy solution with the New Mexico Cancer Center in Albuquerque, NM, USA.

December 22, 2021 — IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, announced it has signed a contract for the installation of a Proteus ONE proton therapy solution with the New Mexico Cancer Center in Albuquerque, NM, USA. The contract includes a long-term operation maintenance agreement.

The contract is for the delivery of a Proteus ONE solution, equipped with Pencil Beam Scanning (PBS), Cone Beam Computed Tomography (CBCT), Hand Pendant with contextual menus for easy patient positioning and the patient focused healthcare environment Philips Ambient Experience. New Mexico Cancer Center expects to treat its first patients by 2024.

The typical end-user price for a Proteus ONE system with a 10-year maintenance contract usually ranges between USD 40-50 million. IBA has received the first payment and will start recognizing revenue in 2021.

Olivier Legrain, Chief Executive Officer of IBA, commented: “This new contract with New Mexico Cancer Center will enable the delivery of IBA’s cutting-edge technology to the citizens of New Mexico for the first time. It is the 7th Proteus ONE system and 19th proton therapy system we have sold in the US, underlining our leading position in the US proton therapy market, and continuing to build upon the strong momentum in the region as we enter 2022. We look forward to collaborating with the team in Albuquerque and are pleased to welcome them to our Campus platform, the largest community of proton therapy experts.”

Barbara McAneny, Chief Executive Officer of New Mexico Cancer Center, said, “As one of the first free-standing cancer centers expanding into Proton therapy, New Mexico Cancer Center selected IBA’s Proteus ONE based on its strong technology and proven track record in hospital based systems.  The delivery of the Proteus One will allow New Mexico Cancer Center to provide the people of New Mexico the ability to access the most advanced solution to fight cancer integrated into other modalities of care, at an affordable cost with the convenience of staying close to home.”

For more information: www.iba-worldwide.com

Related Content

News | Prostate Cancer

July 1, 2022 — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care ...

Time July 01, 2022
arrow
News | Proton Therapy

July 1, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology ...

Time July 01, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

June 30, 2022 — When a patient with head and neck cancer has surgery to remove it, they often need reconstructive ...

Time June 30, 2022
arrow
News | Proton Therapy

June 29, 2022 — ProtOnART builds upon the partners’ long-standing research efforts and shared ambition that an online ...

Time June 29, 2022
arrow
News | Lung Imaging

June 29, 2022 — Building on Penn Medicine’s years of research and use of imaging technology that illuminates tumor ...

Time June 29, 2022
arrow
News | Radiology Business

June 29, 2022 — Siemens Healthineers and The Ohio State University Wexner Medical Center announced a new alliance, aimed ...

Time June 29, 2022
arrow
News | Proton Therapy

June 27, 2022 — Varian, a Siemens Healthineers company, announced that the U.S. Food and Drug Administration (FDA) ...

Time June 28, 2022
arrow
News | Radiation Oncology

June 27, 2022 — Neutron Therapeutics, Inc (NT) and the University Hospital of Brussels (H.U.B) today announced that they ...

Time June 28, 2022
arrow
News | Radiation Therapy

June 24, 2022 — Recently, a collaborated research team led by Prof. LI Hai and Hongzhi Wang from Hefei Institutes of ...

Time June 24, 2022
arrow
News | Radiation Therapy

June 23, 2022 — RaySearch Laboratories AB announced the release of the latest version of RayCare*, the next generation ...

Time June 23, 2022
arrow
Subscribe Now